In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Reliant co-promotes Biovail products; terminated

Executive Summary

Reliant Pharmaceuticals and Biovail have entered into a three-year agreement that extends the deal the two companies signed last month to co-promote Biovail's Teveten, Cedax, and Rondec. The new arrangement adds Biovail's Teveten HCT and its newest product Cardizem XL.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
    • Specialty Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Marketing-Licensing
    • Co-Promotion

Related Companies